Spain

This archive collects solutions-journalism stories and progress milestones from Spain — covering areas such as renewable energy, public health, social policy, and civic innovation. Each entry highlights real developments and measurable outcomes reported from or about Spain.

Infant feet, for article on nirsevimab RSV infant hospitalizations

Spanish study links RSV antibody to 86% drop in infant hospitalizations

By / / Good News For Humankind

Nirsevimab, a long-acting antibody given to every infant in one Spanish region, cut RSV hospitalizations by 86% compared to previous seasons, according to a new study out of Valladolid University. Babies under six months — the group hit hardest by RSV every winter — saw the biggest drop, with pediatric intensive care admissions falling sharply too. Unlike a traditional vaccine, the shot delivers ready-made antibodies directly, which matters for newborns whose immune systems are still developing. Several European countries and the U.S. have already added it to routine infant care, and early data abroad echo the Spanish results. The remaining challenge is making sure families in lower-income countries, where RSV hits hardest, aren’t left waiting.

A researcher examines cancer cells under a microscope for an article about pancreatic tumor regression — 14 words.

Spanish researchers achieve full pancreatic tumor regression in a mouse model study

By / / Good News For Humankind

Pancreatic tumor regression achieved in mice marks a rare and significant breakthrough in one of oncology’s most stubborn challenges. Researchers at Spain’s National Cancer Research Centre induced complete disappearance of established pancreatic tumors by reprogramming the tumor microenvironment, allowing the immune system to recognize and destroy cancer cells. Pancreatic cancer kills the vast majority of patients it affects, with a five-year survival rate below 12%, partly because dense tissue surrounding tumors blocks treatment and hides cancer from immune defenses. While mouse results don’t guarantee human success, this proof of concept signals that full regression in this disease is biologically possible.

A herd of wild horses grazing on an open highland plateau for an article about wild horse rewilding in Spain

Wild horses return to Spain’s Iberian highlands after 10,000 years

By / / Good News For Humankind

Wild horse rewilding in Spain’s central highlands marks a milestone not seen since the last Ice Age, with primitive Iberian breeds returning after a 10,000-year absence. Led by Rewilding Europe and local partners, the project restores a keystone species whose grazing reduces wildfire fuel loads, opens habitat corridors, and disperses seeds across a landscape long diminished by shrub encroachment. Unlike top-down conservation efforts, this initiative was built with landowners and residents from the start, framing the horses’ return as an economic opportunity through nature-based tourism alongside ecological recovery. The horses are back, and the land is already changing.

Medical researcher in a lab examining vials related to asthma and COPD treatment and mRNA vaccine development, for article on benralizumab injection, for article on mRNA lung cancer vaccine

World’s first mRNA lung cancer vaccine enters human trials in seven countries

By / / Good News For Humankind

A landmark mRNA lung cancer vaccine is now being tested in human patients for the first time, marking a historic milestone in cancer treatment. BNT116, developed by BioNTech, uses the same messenger RNA technology behind COVID-19 vaccines to train the immune system to recognize and destroy non-small cell lung cancer cells. The phase 1 trial spans 34 sites across seven countries, with roughly 130 patients enrolled. Unlike chemotherapy, this approach targets only tumor cells, potentially offering a more precise and lasting defense against the world’s deadliest cancer, which kills 1.8 million people annually.

Iberian lynx, for article on Iberian lynx recovery

Iberian lynx no longer endangered after numbers improve in Spain and Portugal

By / / Good News For Humankind

The Iberian lynx has climbed from just 94 individuals in 2002 to 2,021 today, earning a reclassification from “endangered” to “vulnerable” on the IUCN Red List. Two decades ago, the world’s most threatened wild cat was confined to two small populations in southern Spain and widely expected to vanish. What turned things around was patient, unglamorous work: breeding programs, reintroductions across Spain and Portugal, rabbit recovery efforts, and local communities choosing to share their land with an animal once treated as vermin. Threats remain — road deaths, rabbit disease, and climate change — but the lynx now stands as living proof that coordinated, cross-border conservation can pull a species back from the edge, offering a template for recoveries elsewhere.

Lynx, for article on Iberian highlands rewilding

Lynx, wild horses and vultures return to eastern Spain in latest rewilding project

By / / Good News For Humankind

Rewilding Europe’s first project in Spain is bringing an 850,000-acre mountain landscape back to life — and the early signs are genuinely hopeful. Wild horses are already breeding, black vultures are being released at up to 15 a year, and Iberian lynx are expected within two years. The project is also designed around local communities, creating economic incentives for nature-based tourism and forest protection. Stories like this show that recovery is possible when wildlife, people, and landscape are treated as one connected system.